Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05538286 · ClinicalTrials.gov registry record · NA
Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation
A NA study of Transcranial Ultrasound With Sonolucent Cranioplasty and TUSC, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05538286 is a NA study of Transcranial Ultrasound With Sonolucent Cranioplasty and TUSC that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05538286, a NA study of Transcranial Ultrasound With Sonolucent Cranioplasty and TUSC, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Postoperative rebleeding is a major limitation of surgical evacuation for intracerebral hemorrhage (ICH). While computed tomography (CT) is the standard of care for postoperative hematoma cavity monitoring, CT requires significant physical and financial costs. Studies have demonstrated varying degrees of efficacy when using transcranial ultrasound to measure ICH volume. Recently, synthetic implants for cranioplasty have been shown to be safe and sonolucent. This study aims to evaluate the ability of transcranial ultrasound with sonolucent cranioplasty (TUSC) to detect and quantify bleeding in postoperative ICH patients.
Conditions Studied
Interventions
- DEVICE ClearFit implant
- PROCEDURE transcranial ultrasonography through sonolucent cranioplasty
Study Locations (1)
New York
- Mount Sinai Health System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-09-23 |
| Est. Completion | 2025-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05538286
The ClinicalTrials.gov registry entry for NCT05538286 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Transcranial Ultrasound With Sonolucent Cranioplasty appearing as the primary indexed condition, and to 2 interventions - of which ClearFit implant is the first listed.
NCT05538286 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05538286 about?
NCT05538286 is a clinical study titled "Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation". Postoperative rebleeding is a major limitation of surgical evacuation for intracerebral hemorrhage (ICH). While computed tomography (CT) is the standard of care for postoperative hematoma cavity monitoring, CT requires significant physical and financial costs. Studies have demonstrated varying degre...
What is the current status of trial NCT05538286?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-09-23. Estimated completion is 2025-09.
What conditions does trial NCT05538286 study?
This clinical trial studies the following conditions: Transcranial Ultrasound With Sonolucent Cranioplasty, TUSC.
What interventions are being tested in trial NCT05538286?
The interventions under investigation include: ClearFit implant (DEVICE), transcranial ultrasonography through sonolucent cranioplasty (PROCEDURE).
Who is sponsoring clinical trial NCT05538286?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05538286 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.